v3.25.1
Condensed Consolidated Statements of Earnings and Comprehensive Income - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]        
Net sales $ 580.7 $ 599.4 $ 1,059.1 $ 1,088.3
Cost of products sold 324.5 341.3 611.3 632.5
Gross profit 256.2 258.1 447.8 455.8
Selling, general and administrative expense 105.7 107.5 208.6 210.8
Advertising and sales promotion expense 65.5 63.1 115.8 111.3
Research and development expense 13.9 14.2 27.8 27.5
Restructuring charges 12.2 3.2 16.4 10.0
Operating income 58.9 70.1 79.2 96.2
Interest expense associated with debt 20.2 20.4 39.0 40.2
Other (income) expense, net (2.6) 2.7 0.6 3.0
Earnings before income taxes 41.3 47.0 39.6 53.0
Income tax provision 12.3 11.0 12.7 12.2
Net earnings 29.0 36.0 26.9 40.8
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax 23.0 (16.0) (25.3) 11.0
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax 0.3 (0.5) 0.7 (0.6)
Deferred gain (loss) on hedging activity, net of tax $ (2.8) $ 2.7 $ 2.2 $ (0.7)
Basic net earnings per share $ 0.60 $ 0.72 $ 0.56 $ 0.82
Diluted net earnings per share $ 0.60 $ 0.72 $ 0.55 $ 0.81
Condensed Consolidated Statements of Comprehensive Income        
Net earnings $ 29.0 $ 36.0 $ 26.9 $ 40.8
Other comprehensive (loss) income, net of tax        
Total other comprehensive (loss) income, net of tax 20.5 (13.8) (22.4) 9.7
Total comprehensive income $ 49.5 $ 22.2 $ 4.5 $ 50.5
Basic weighted-average shares outstanding (in shares) 48.0 49.8 48.3 50.0
Weighted Average Number of Shares Outstanding, Diluted 48.2 50.2 48.4 50.3